23. Structure-Based De Novo Design and Biochemical Evaluation of Novel BRAF Kinase Inhibitors
Park, H.; Jeong, Y.; Hong, S.
Bioorg. Med. Chem. Lett. 2012, 22. 1027.
22. Nocodazole is a High-Affinity Ligand for the Cancer-Related Kinases ABL, c-KIT, BRAF, and MEK
Park, H.; Hong, S.; Hong, S.
ChemMedChem. 2012, 7, 53-56.
21. A Novel Imidazopyridine Analogue as a Phosphatidylinositol 3-Kinase Inhibitor against Human Breast Cancer
Lee, H.; Li, G.-Y.; Jeong, Y.; Jung, K. H.; Lee, J.-H.; Ham, K.; Hong, S.*; Hong, S.-S.*
Cancer Lett. 2012, 318, 68.
20. Identification of Novel Inhibitors of Tropomyosin-Related Kinase A through the Structure-Based Virtual Screening with Homology-Modeled Protein Structure
Park, H.; Chi, O.; Kim, J.; Hong, S.
J. Chem. Inform. Mod. 2011, 51, 2986-2993.
19. Discovery of New Aminopyrimidine-based Phosphoinositide 3-kinase beta (PI3Kb) Inhibitors with Selectivity over PI3Ka
Kim, J.; Hong, S.; Hong, S.
Bioorg. Med. Chem. Lett. 2011, 21, 6977.
18. Palladium(II)-Catalyzed Direct Intermolecular Alkenylation of Chromones
Kim, D.; Hong, S.
Org. Lett. 2011, 13, 4466-4469.
17. Identification of Novel BRAF Kinase Inhibitors with Structure-Based Virtual Screening
Park, H.; Choi, H.; Hong, S.; Hong, S.
Bioorg. Med. Chem. Lett. 2011, 21, 5753.
16. Synergistic Effect of Graphene Oxide/MWCNT Films in Laser Desorption/Ionization Mass Spectrometry of Small Molecules and Tissue Imaging
Kim, Y.-K.; Na, H.-K.; Kwack, S.-J.; Ryoo, S.-R.; Lee, Y.; Hong, S.; Hong, S.; Jeong, Y.; Min, D.-H.
ACS. Nano. 2011, 5, 4550-4561.
15. Overcoming Metastatic Melanoma with BRAF Inhibitors
Hong, S.; Hong, S.
Arch. Pharm. Res. 2011, 34, 699-701.
14. Anti-cancer effects of a novel compound HS-113 on cell growth, apoptosis, and angiogenesis in human hepatocellular carcinoma cells
Choi, M; Jung, K. H.; Kim, D.; Lee, H.; Zheng, H.;Park, B. H.; Hong, S.-W., Kim, M.; Hong, S.*; Hong, S.-S.*
Cancer Lett. 2011, 306, 190.
